Metallothionein-null mice are more sensitive than wild-type mice to liver injury induced by repeated exposure to cadmium

Toxicological Sciences

Volumn 55, Issue 1, 2000, Pages 223-232

  Habeebu, Sultan S ^a   Liu, Jie ^a   Liu, Yaping ^a   Klaassen, Curtis D ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cadmium (Cd) toxicity; Iver toxicity; Metallothionein (MT); Necrosis

Indexed keywords

CADMIUM; METALLOTHIONEIN;

ACUTE TOXICITY; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY BURDEN; BODY WEIGHT; CHRONIC TOXICITY; CONTROLLED STUDY; LIVER NECROSIS; LIVER TOXICITY; LIVER WEIGHT; MOUSE; NONHUMAN;

EID: 0034103448     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/55.1.223     Document Type: Article

References (40)

1. Biggart, N. W., and Murphy, E., Jr. (1988). Analysis of metal-induced mutations altering the expression or structure of a retroviral gene in a mammalian cell line. Mutat. Res. 198, 115-129.
2. Brys, M., Nawrocka, A. D., Miekos, E., Zydek, C., Foksinski, M., Barecki, A., and Krajewska, W. M. (1997). Zinc and cadmium analysis in human prostate neoplasms. Biol. Trace Elem. Res. 59, 145-152.
3. Cherian, M. G. (1995). Metallothionein and its interaction with metals. In Toxicology of Metals: Biochemical Aspects (R. A. Goyer and M. G. Cherian, Eds.), pp. 121-138. Springer-Verlag., New York.
4. Coogan, T. P., Bare, R. M., and Waalkes, M. P. (1992). Cadmium-induced DNA strand damage in cultured liver cells: Reduction in cadmium genotoxicity following zinc pretreatment. Toxicol. Appl. Pharmacol. 113, 227-233.
5. Darewicz, G., Malczyk, E., and Darewicz, J. (1998). Investigations of urinary cadmium content in patients with urinary bladder carcinoma. Int. Urol. Nephrol. 30, 137-139.
6. Dong, W., Simeonova, P. P., Gallucci, R., Matheson, J., Flood, L., Wang, S., Hubbs, A., and Luster, M. I. (1998). Toxic metals stimulate inflammatory cytokines in hepatocytes through oxidative stress mechanisms. Toxicol. Appl. Pharmacol. 151, 359-366.
7. Dudley, R. E., Gammal, L. M. and Klaassen, C. D. (1985). Cadmium-induced hepatic and renal injury in chronically exposed rats: Likely role of hepatic cadmium-metallothionein in nephrotoxicity. Toxicol. Appl. Pharmacol. 77, 414-426.
8. Dudley, R. E., Svoboda, D. J., and Klaassen, C. (1982). Acute exposure to cadmium causes severe liver injury in rats. Toxicol. Appl. Pharmacol. 65, 302-313.
9. Dudley, R. E., Svoboda, D. J., and Klaassen, C. D. (1984). Time course of cadmium-induced ultrastructural changes in rat liver. Toxicol. Appl. Pharmacol. 76, 150-160.
10. Eaton, D. L., and Toal, B. F. (1982). Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological tissues. Toxicol. Appl. Pharmacol. 66, 134-142.
11. Faeder, E. J., Chaney, S. Q., King, L. C., Hinners, T. A., Bruce, R., and Fowler, B. A. (1977). Biochemical and ultrastructural changes in livers of cadmium-treated rats. Toxicol. Appl. Pharmacol. 39, 473-487.
12. Goering, P. L., and Klaassen, C. D. (1983). Altered subcellular distribution of cadmium following cadmium pretreatment: Possible mechanism of tolerance to cadmium-induced lethality. Toxicol. Appl. Pharmacol. 70, 195-203.
13. Goering, P. L., and Klaassen, C. D. (1984). Tolerance to cadmium-induced hepatotoxicity following cadmium pretreatment. Toxicol. Appl. Pharmacol. 74, 308-313.
14. Habeebu, S. S., Liu, J., and Klaassen, C. D. (1998). Cadmium-induced apoptosis in mouse liver. Toxicol. Appl. Pharmacol. 149, 203-209.
15. 2-induced bone injury. Toxicol. Sci. (in press).
16. Hartwig, A. (1994). Role of DNA repair inhibition in lead- and cadmium-induced genotoxicity: a review. Environ. Health. Perspect. 3, 45-50.
17. Hartwig, A. (1998). Carcinogenicity of metal compounds: possible role of DNA repair inhibition. Toxicol. Lett. 102-103, 235-239.
18. Hoffmann, E. O., Cook, J. A., di, Luzio, N. R., and Coover, J. A. (1975). The effects of acute cadmium administration in the liver and kidney of the rat: Light and electron microscopic studies. Lab. Invest. 32, 655-664.
19. IARC. (1993). International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risks to Humans. Volume 58, Beryllium, Cadmium, Mercury, and Exposures in the Glass Industry, pp. 119-238. IARC Scientific Publications. Lyon.
20. Kagi, J. H. R. (1993). Evolution, structure, and chemical activity of class I metallothioneins: an overview. In Metallothionein III: Biological Roles and Medical Implications (K. T. Suzuki, N. Imura, and M. Kimura, Eds.), pp. 29-56. Birkhauser Verlag, Berlin.
21. Kamiyama, T., Miyakawa, H., Li, J. P., Akiba, T., Liu, J. H., Liu, J., Marumo, F., and Sato, C. (1995). Effects of one-year cadmium exposure on livers and kidneys and their relation to glutathione levels. Res. Commun. Mol. Pathol. Pharmacol. 88, 177-186.
22. Kayama, F., Yoshida, T., Elwell, M. R., and Luster, M. I. (1995). Role of tumor necrosis factor-alpha in cadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131, 224-234.
23. Kondo, Y., Rusnak, J. M., Hoyt, D. G., Settineri, C. E., Pitt, B. R., and Lazo, J. S. (1997). Enhanced apoptosis in metallothionein null cells. Mol. Pharmacol. 52, 195-201.
24. Liu, J., Liu, Y., Habeebu, S. S., and Klaassen, C. D. (1998a). Metallothionein (MT)-null mice are sensitive to cisplatin-induced hepatotoxicity. Toxicol. Appl. Pharmacol 149, 24-31.
25. 2-induced nephrotoxicity indicates that renal injury is not mediated by the CdMT complex. Toxicol. Sci. 46, 197-203.
26. 2 exposure. Toxicol. Appl. Pharmacol. 159, 98-108.
27. Liu, Y., Liu, J., Habeebu, S. S., and Klaassen, C. D. (1999b). Metallothionein protects against the nephrotoxicity produced by chronic CdMT exposure. Toxicol. Sci. 50, 221-227.
28. Liu, Y., Liu, J., Iszard, M. B., Andrews, G., Palmiter, R. D., and Klaassen, C. D. (1995). Transgenic mice that overexpress metallothionein-1 are protected from cadmium lethality and hepatotoxicity. Toxicol. Appl. Pharmacol. 135, 222-228.
29. Liu, J., Liu, Y., Michalska, A. E., Choo, K. H., and Klaassen, C. D. (1996a). Distribution and retention of cadmium in metallothionein I and II null mice. Toxicol. Appl. Pharmacol. 136, 260-268.
30. Liu, J., Liu, Y., Michalska, A. E., Choo, K. H., and Klaassen, C. D. (1996b). Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity. J. Pharmacol. Exp. Ther. 276, 1216-1223.
31. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., and Palmiter, R. D. (1994). Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. U S A 91, 584-588.
32. Michalska, A. E., and Choo, K. H. (1993). Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc. Natl. Acad. Sci. U S A 90, 8088-8092.
33. Moch, R. W., Dua, P. N., and Hines, F. A. (1996). Problems in consideration of rodent hepatocarcinogenesis for regulatory purposes. Toxicol. Pathol. 24, 138-145.
34. Petering, D. H., and Fowler, B. A. (1986). Uptake of galactose, ouabain, and taurocholate into centrilobular- and periportal-enriched hepatocyte subpopulations. Environ. Health Perspect. 65, 217-224.
35. Popp, J. A., and Cattley, R. C. (1991). Hepatobiliary system. In Handbook of Toxicologic Pathology (W. M. Haschek and C. G. Rousseaux. Eds.), pp. 279-314. Academic Press, San Diego.
36. Waalkes, M. P., Anver, M. R., and Diwan, B. A. (1999). Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes. J. Toxicol. Environ. Health 58, 199-214.
37. Waalkes, M. P., and Diwan, B. A. (1999). Cadmium-induced inhibition of the growth and metastasis of human lung carcinoma xenografts: Role of apoptosis. Carcinogenesis 20, 65-70.
38. Waalkes, M. P., and Rehm, S. (1994). Chronic toxic and carcinogenic effects of cadmium chloride in male DBA/2NCr and NFS/NCr mice: Strain-dependent association with tumors of the hematopoietic system, injection site, liver, and lung. Fundam. Appl. Toxicol. 23, 21-31.
39. Waalkes, M. P., Diwan, B. A., Rehm, S., Ward, J. M., Moussa, M., Cherian, M. G., and Goyer, R. A. (1996). Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice. J. Pharmacol. Exp. Ther. 277, 1026-1033.
40. Waalkes, M. P., Harvey, M. J., and Klaassen, C. D. (1984). Relative in vitro affinity of hepatic metallothionein for metals. Toxicol. Lett. 20, 33-39.